MediciNova Inc. (MNOV) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

MediciNova Inc.

NASDAQ: MNOV · Real-Time Price · USD
1.28
0.04 (3.23%)
At close: Oct 03, 2025, 3:48 PM
1.28
0.00%
After-hours: Oct 03, 2025, 07:38 PM EDT

MediciNova Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
134.6K n/a n/a n/a n/a n/a -999.77M 1B n/a n/a n/a n/a n/a n/a 4.03B 37.5K n/a 4M
Cost of Revenue
116.35K 5.18K 5.18K 5.18K n/a 5.35K 5.49K 5.7K 54.12K 53.62K 47.93K 54.19K 60.7K 49.61K 6.37K n/a 6.15K n/a
Gross Profit
18.25K -5.18K -5.18K -5.18K -5.37K -5.35K -999.78M 999.99M -54.12K -53.62K -47.93K -54.19K -60.7K -49.61K 4.03B 37.5K -6.15K 4M
Operating Income
-3.61M -3.2M -3.18M -3.31M -3.05M -3.14M -2.49M -1.15B -3.3M -2.96M -3.23M -3.9M -4.09M -3.41M -2.1M -3.6M -4.31M -201.53K
Interest Income
324.95K 336.11K 390.1K 447.85K 435.35K 397.51K 436.26K 437.93K 451.42K 509.05K 427.3K 253.75K 91.28K 37.34K 36.47K 36.15K 34.34K 36.67K
Pretax Income
-3.28M -2.86M -2.81M -2.85M -2.63M -2.75M -2.06M -723.11K -2.87M -2.92M -3M -3.65M -4.03M -3.39M -2.08M -3.58M -4.28M -187.8K
Net Income
-3.28M -2.86M -2.81M -2.85M -2.63M -2.75M -2.06M -723.11K -2.87M -2.87M -3M -3.41M -3.97M -3.36M -2.08M -3.58M -4.28M -187.8K
Selling & General & Admin
1.44M 1.36M 1.28M 1.45M 1.4M 1.35M 839.33K 1.35B 1.56M 1.49M 1.22M 1.44M 1.52M 1.3M 325.82K 1.55M 1.78M 2.06M
Research & Development
2.19M 1.84M 1.91M 1.86M 1.65M 1.78M 1.65M 794.71M 1.74M 1.48M 2.01M 2.45M 2.56M 2.11M 1.78M 2.09M 2.53M 2.15M
Other Expenses
n/a n/a -5.18K n/a n/a -16.04K -2.2K -14.15K -23.21K -463.31K -194.73K -8.47K -30.34K -13.74K -14.21K -13.38K -8.97K -22.94K
Operating Expenses
3.63M 3.2M 3.18M 3.31M 3.05M 3.13M 2.49M 2.15B 3.3M 2.96M 3.23M 3.9M 4.09M 3.41M 2.1M 3.64M 4.31M 4.2M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 63.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.74M 3.2M 3.18M 3.31M 3.05M 3.14M 2.49M 2.15B 3.3M 2.96M 3.23M 3.9M 4.09M 3.41M 2.1M 3.64M 4.31M 4.2M
Income Tax Expense
n/a n/a 5.54K n/a n/a n/a -433.22K -1.15B n/a -45.74K 2.82K -245.28K -60.94K -23.59K -33.9K n/a -34.34K n/a
Shares Outstanding (Basic)
49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.04M 48.99M 48.99M 48.8M 47.54M
Shares Outstanding (Diluted)
49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.04M 48.99M 48.99M 48.8M 47.54M
EPS (Basic)
-0.07 -0.06 -0.06 -0.06 -0.05 -0.06 -0.04 -0.01 -0.06 -0.06 -0.06 -0.07 -0.08 -0.07 -0.04 -0.07 -0.09 -0.00
EPS (Diluted)
-0.07 -0.06 -0.06 -0.06 -0.05 -0.06 -0.04 -0.01 -0.06 -0.06 -0.06 -0.07 -0.08 -0.07 -0.04 -0.07 -0.09 -0.00
EBITDA
-3.6M -3.2M -3.18M -3.3M -3.04M -3.13M -2.48M -1.14M -3.3M -2.96M -3.23M -3.89M -4.09M -3.41M -2.1M -3.59M -4.3M -195.08K
EBIT
-3.61M -3.2M -3.18M -3.31M -3.05M -3.14M -2.49M -1.15M -3.3M -2.96M -3.23M -3.9M -4.09M -3.41M -2.1M -3.6M -4.31M -201.53K
Depreciation & Amortization
5.06K 5.18K 5.18K 5.18K 5.37K 5.35K 5.49K 5.7K 54.12K 53.62K 47.93K 54.19K 60.7K 49.61K 6.37K 7.17K 6.15K 6.45K